Literature DB >> 8336173

The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register.

A M Chancellor1, J M Slattery, H Fraser, R J Swingler, S M Holloway, C P Warlow.   

Abstract

The Scottish Motor Neuron Disease Register (SMNDR) is a prospective, collaborative, population-based project which has been collecting data on incident patients since 1989. In this report we present the clinical features of 229 patients with motor neuron disease (218 sporadic and 11 familial) diagnosed in 1989 and 1990 and compare their prognosis with previous studies of survival. The overall 50% survival from symptom onset was 2.5 years (95% CI, 2.2-3.0) and 5-year survival 28% (95% CI, 20-36%). The presence of progressive bulbar palsy (PBP), either at presentation or developing during the course of the illness, significantly reduced survival and was the most important prognostic indicator. Patients who survived longer than 5 years from symptom onset did not have PBP as part of their presenting illness. The prognosis was worse for women, and this was in part related to the higher frequency of PBP in older women, but age was also an independent adverse risk factor. Differences in survival between this and previous series can probably be explained on the basis of variation in case definition and ascertainment methods.

Entities:  

Mesh:

Year:  1993        PMID: 8336173     DOI: 10.1007/bf00839964

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy.

Authors:  R K Olney; M J Aminoff; Y T So
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

3.  Clinical features and associations of 560 cases of motor neuron disease.

Authors:  T M Li; E Alberman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

4.  The prognosis of motor neuron disease in Nigerian africans. A prospective study of 92 patients.

Authors:  B O Osuntokun; A O Adeuja; O Bademosi
Journal:  Brain       Date:  1974-06       Impact factor: 13.501

5.  More favourable prognosis of motor neurone disease in old age.

Authors:  H M Hodkinson
Journal:  Age Ageing       Date:  1972-08       Impact factor: 10.668

6.  A survival analysis of 155 cases of progressive muscular atrophy.

Authors:  A Chiò; F Brignolio; M Leone; P Mortara; M G Rosso; A Tribolo; D Schiffer
Journal:  Acta Neurol Scand       Date:  1985-10       Impact factor: 3.209

7.  Patient resistance and prognosis in amyotrophic lateral sclerosis.

Authors:  D W Mulder; F M Howard
Journal:  Mayo Clin Proc       Date:  1976-09       Impact factor: 7.616

8.  Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

Authors:  S S Gubbay; E Kahana; N Zilber; G Cooper; S Pintov; Y Leibowitz
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

9.  Amyotrophic lateral sclerosis. Clinical features and prognosis.

Authors:  A D Rosen
Journal:  Arch Neurol       Date:  1978-10

10.  Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis.

Authors:  A Chio; F Brignolio; P Meineri; D Schiffer
Journal:  Acta Neurol Scand       Date:  1987-04       Impact factor: 3.209

View more
  30 in total

1.  ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.

Authors:  A Chiò
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

2.  Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.

Authors:  Farrah J Mateen; Marco Carone; Eric J Sorenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

Review 3.  Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; April L McVey; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 4.  Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).

Authors:  Omar Jawdat; Jeffrey M Statland; Richard J Barohn; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 5.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 6.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

7.  Changing epidemiology of motor neurone disease in Scotland.

Authors:  Danielle J Leighton; Judith Newton; Laura J Stephenson; Shuna Colville; Richard Davenport; George Gorrie; Ian Morrison; Robert Swingler; Siddharthan Chandran; Suvankar Pal
Journal:  J Neurol       Date:  2019-02-25       Impact factor: 4.849

8.  Development of a biomarker database toward performing disease classification and finding disease interrelations.

Authors:  Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Aki Morita; Shigehiko Kanaya; Md Altaf-Ul-Amin
Journal:  Database (Oxford)       Date:  2021-03-11       Impact factor: 3.451

9.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.